Elaherehcp.com

Dosing and Administration ELAHERE® (mirvetuximab …

Based on its mechanism of action, ELAHERE can cause embryo-fetal harm when administered to a pregnant woman because it contains a genotoxic compound (DM4) and affects actively dividing cells. Advise pregnant women of the potential risk to a … See more

Actived: 3 days ago

URL: https://www.elaherehcp.com/dosing

ELAHERE® (mirvetuximab soravtansine-gynx) HCP Website

WebPatient portrayal. ELAHERE is indicated for the treatment of adult patients with folate receptor-alpha (FRα) positive, platinum-resistant epithelial ovarian, fallopian tube, or …

Category: Health Go Health

Practice and Patient Support ELAHERE® (mirvetuximab …

WebEffective July 1, 2023, the permanent J-Code for ELAHERE is J9063 - Injection, mirvetuximab soravtansine-gynx, 1 mg. ‡. The Centers for Medicare & Medicaid …

Category: Health Go Health

Eye Care ELAHERE® (mirvetuximab soravtansine-gynx) HCP …

WebOcular Disorders. ELAHERE can cause severe ocular adverse reactions, including visual impairment, keratopathy (corneal disorders), dry eye, photophobia, eye pain, and uveitis. …

Category: Health Go Health

About ELAHERE® (mirvetuximab soravtansine-gynx) HCP Website

WebTargeting FRα—ELAHERE mechanism of action 1,8,10,11. ELAHERE is an ADC that binds to tumor surface receptor FRα. Upon binding to the FRα receptor, ELAHERE is …

Category: Health Go Health

Efficacy ELAHERE® (mirvetuximab soravtansine-gynx) HCP …

WebELAHERE can cause severe ocular toxicities, including visual impairment, keratopathy, dry eye, photophobia, eye pain, and uveitis. Conduct an ophthalmic exam including visual …

Category: Health Go Health

Safety ELAHERE® (mirvetuximab soravtansine-gynx) HCP Website

WebELAHERE can cause severe ocular toxicities, including visual impairment, keratopathy, dry eye, photophobia, eye pain, and uveitis. Conduct an ophthalmic exam including visual …

Category: Health Go Health

BILLING AND CODING GUIDE

WebPlease see additional Important Safety Information for ELAHERE, including Boxed Warning on pages 11-12, and click to access full Prescribing Information.

Category: Health Go Health

ELAHERE (mirvetuximab soravtansine-gynx) Enrollment Form

WebPhone: 1-833-352-4373 | Fax: 1-833-464-6329 | Monday to Friday, 8 am to 8 pm ET ELAHERE™ (mirvetuximab soravtansine-gynx) Enrollment Form PRESCRIBER …

Category: Health Go Health

Ordering Information

WebPlease see full Prescribing Information, including Boxed Warning. ELAHERE® PRODUCT INFORMATION 100 mg/20 mL (5 mg/mL) in a single-dose vial NDC: 72903-0853-01 …

Category: Health Go Health

Request a Rep ELAHERE® (mirvetuximab soravtansine-gynx

WebOcular Disorders. ELAHERE can cause severe ocular adverse reactions, including visual impairment, keratopathy (corneal disorders), dry eye, photophobia, eye pain, and uveitis. …

Category: Health Go Health

SAMPLE Letter of Appeals

Web4 The most common (≥20%) adverse reactions, including laboratory abnormalities, were vision impairment, fatigue, increased aspartate aminotransferase, nausea, increased …

Category: Health Go Health